<SEC-DOCUMENT>0001193125-17-263721.txt : 20170821
<SEC-HEADER>0001193125-17-263721.hdr.sgml : 20170821
<ACCEPTANCE-DATETIME>20170821164603
ACCESSION NUMBER:		0001193125-17-263721
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170817
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170821
DATE AS OF CHANGE:		20170821

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		171043478

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d418725d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, DC&nbsp;20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(D) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of report (Date of earliest event reported):&nbsp;August&nbsp;21, 2017 (August 17, 2017) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Humana Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name
of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Delaware
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of Incorporation) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-5975</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">61-0647538</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Commission File Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(IRS Employer Identification No.)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>500 West Main Street, Louisville, KY</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>40202</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">502-580-1000</FONT></FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s Telephone Number, Including Area Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former Name or Former Address, if Changed Since Last Report) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions (<I>see </I>General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17&nbsp;CFR&nbsp;230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act
<FONT STYLE="white-space:nowrap">(17&nbsp;CFR&nbsp;240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act
<FONT STYLE="white-space:nowrap">(17&nbsp;CFR&nbsp;240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an
emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934
<FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Effective August&nbsp;17, 2017, the Board of Directors (the &#147;Board&#148;) of Humana Inc. (the &#147;Company&#148;) expanded its number of authorized
directors from ten to eleven and elected Mr.&nbsp;Frank&nbsp;J. Bisignano as a director of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Board of Directors has
determined that (i)&nbsp;Mr.&nbsp;Bisignano is independent within the meaning of the New York Stock Exchange&#146;s director independence standards; (ii)&nbsp;there was no arrangement or understanding between Mr.&nbsp;Bisignano and any other persons
pursuant to which Mr.&nbsp;Bisignano was selected as a director; and (iii)&nbsp;there are no material transactions involving Mr.&nbsp;Bisignano and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Bisignano will be compensated in accordance with the Company&#146;s standard compensation policies and practices for the Board, the
components of which were disclosed in a current report filed by the Company with the U.S. Securities and Exchange Committee on July&nbsp;5, 2017. In connection with his election to the Board, Mr.&nbsp;Bisignano also will be granted restricted stock
units (RSUs) in accordance with the Company&#146;s director compensation program. The number of the RSUs granted will be a pro rata portion of the annual stock compensation for our directors, and will be determined based upon the value of the
Company&#146;s stock as of the grant date. Mr.&nbsp;Bisignano has not yet been appointed to any committees of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On
August&nbsp;21, 2017, the Company issued a press release announcing the election of Mr.&nbsp;Bisignano, a copy of which is attached hereto as Exhibit 99.1, and is incorporated by reference herein. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP><B>99.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Press Release, dated August&nbsp;21, 2017</B></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>HUMANA INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>BY:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>/s/ Cynthia H. Zipperle</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Cynthia H. Zipperle</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Vice President, Chief Accounting Officer<BR>and Controller</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;21, 2017 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX TO EXHIBITS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP><B>99.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Press Release, dated August&nbsp;21, 2017</B></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d418725dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>n e w s </B>r e l e a s e </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>FOR MORE INFORMATION, CONTACT:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4" ALIGN="right">


<IMG SRC="g418725imag2.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Humana Investor
Relations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amy Smith,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">502-580-2811</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>asmith3@humana.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Humana Corporate
Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tom Noland, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">502-580-3674</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>tnoland@humana.com </U></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Humana Elects Frank
Bisignano to Board of Directors </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LOUISVILLE, Ky. </B>&#151; August&nbsp;21, 2017 &#151; Humana Inc. (NYSE: HUM) announced today that Frank
Bisignano has been elected as a member of the company&#146;s board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bisignano, 58, is Chairman of the Board and Chief Executive Officer of
First Data, a global leader in commerce-enabling technology and solutions. Since joining First Data in 2013, he has been instrumental in transforming the company from its position as a traditional payment processor into a technology innovator,
industry collaborator and commerce enabler. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to his tenure at First Data, Bisignano was <FONT STYLE="white-space:nowrap">co-Chief</FONT> Operating
Officer for J.P. Morgan Chase and Chief Executive Officer of its Mortgage Banking unit. Earlier in his career, he held several executive roles at Citigroup that included serving on the bank&#146;s management committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Frank is a proven business leader who understands the importance of technology as a solution to complex problems, which is a key part of Humana&#146;s
strategy to integrate a fragmented health care system through leveraging technology,&#148; said Humana Chairman of the Board Kurt J. Hilzinger. &#147;We believe this integration sits at the heart of a health care system that considers and cares for
the &#145;whole person&#146; while delivering true value. The depth and breadth of Frank&#146;s experiences and insights will serve our Board of Directors well.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bisignano&#146;s election brings the number of Humana directors to 11. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Humana </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Humana Inc. is committed to helping
our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and
lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients,
our members. Our range of clinical capabilities, resources and tools &#150; such as <FONT STYLE="white-space:nowrap">in-home</FONT> care, behavioral health, pharmacy services, data analytics and wellness solutions &#150; combine to produce a
simplified experience that makes health care easier to navigate and more effective. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>n e w s </B>r e l e a s e<B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">More information regarding Humana is available to investors via the Investor Relations page of the
company&#146;s web site at <U>www.humana.com</U>, including copies of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual reports to stockholders </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Securities and Exchange Commission filings </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Most recent investor conference presentations </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Quarterly earnings news releases and conference calls </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Calendar of events </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Corporate Governance information </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g418725imag2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g418725imag2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /@#[ P$1  (1 0,1 ?_$ -(   (" @,! 0
M       (!PD! @,$!@4* 0 !!0$! 0$              04&!P@$ @,)$
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M%Q$+7L%^V_HI8!1@5B%[;A\(6_'0$'+2 !0 %  4 !0 %  4 !0 %  4 !0
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M6E0@7?\ ZA:.U.?Y)MM ;?O9J:QH6B3J8E'16L.=1ZW*X%-%%H120$A2#_.
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M.\&D*GBESEW6U%FCKS'JZ(";TNJIJ;:C3AE(N^/Q!W0JTWO53UAT,9KG" H
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M ISE/0YI,*KU .7+;O:.+Q+/-O<?:X\VEY]_ 3$*P*<D2J/NCMRW=IM1.**
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MXP^\Q?\ 3,. /@+&.JGG#GA:L\1:-DCP<#M911D78\B?!0K/Y@$A#>W=T!
M,.X^3J$+;Z8)2"QC$\+ZJR!6F#_F$N<+_"G<>M7] @,]^,._O4^)C]+FT)M.
MV6V@:;:]OL0"W9:\&P'C\%?I];[A3%'9?+0<GX$0O%K VR+1LD^ J[ZJ0Z7&
MSPCP#7EP /I.)8G23P$XUC;BCB=P2T?]@1_#G%:W_P#JT\N/B/1=*4@DQG>X
M!'B.38:/HM^II4+>H2U9G#41'8SO27@H2&Q8?=A0Y"\PB/.C_><W3_UZ-_8[
M&LL;SR(K]F(?MB\1 :[_ !"][1>8N\Y+/[K^S_\ 5D_[2?5^A.[0B_(LE[)>
M)"VZ7^'-= 63J@?V28<'=]_4/EBGM_CJ@^*HS.G,\R50YL$Z!'+T_P!(WTJ\
M@OO2PL&Y6Z7&W[D1/#TVF%>/JIDX75*-I_,9G]CR^T/A9V"%PY"\PJ?.=8W,
MKNLD%M7O;-0H_G>5"L#"7POJK/E__P ?3<-4QYB%U<B5<BXE'TA>URE*IGY;
M-FS:K%^Y$78; -[BN40]0D^6OT8W;-*=LVG8G'9GY"WI"'N*/9"E=4@+;5X*
M/<.?(?LQY6=^*IM3<K(8GBI[N)L0V\H')ETGY"#^E=PSG=HW_I^-DM_C)A4M
M_53EPP&?W=,'^Z\5!SLTB*FG#D+S%VQ?H!ZP^(:UVZ6GH$OUC>FHO6,>04H
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MV[ZDFZVP6]W=)<D?>"F%.Y-'S<I*+OS=P]T*D_=<N<?GP[OE$B[[<N>WV_\
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)Q&U 0%( ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
